Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department

Citation
Dr. Touchette et Dh. Rhoney, Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department, PHARMACOTHE, 20(8), 2000, pp. 910-918
Citations number
28
Categorie Soggetti
Pharmacology
Journal title
PHARMACOTHERAPY
ISSN journal
02770008 → ACNP
Volume
20
Issue
8
Year of publication
2000
Pages
910 - 918
Database
ISI
SICI code
0277-0008(200008)20:8<910:CAOPAF>2.0.ZU;2-Y
Abstract
Study Objective. To determine the value of fosphenytoin compared with pheny toin for treating patients admitted to an emergency department following a seizure. Design, Cost-minimization analysis performed from a hospital perspective. Setting. Hospital emergency department. Patients. Two hundred fifty-six patients participating in a comparative cli nical trial. Intervention. Estimation of adverse event rates and resource use. Measurements and Main Results. In our base case, phenytoin was the preferre d option, with an expected total treatment cost of $5.39 compared with $110 .14 for fosphenytoin. One-way sensitivity analyses showed that the frequenc y and cost of treating purple glove syndrome (PGS) possibly could affect th e decision. Monte Carlo simulation showed phenytoin to be the preferred opt ion 97.3% of the time. Conclusion. When variable costs of care are used to calculate the value of phenytoin compared with fosphenytoin in the emergency department, phenytoin is preferred. The decision to administer pl phenytoin was very robust and changed only when both the frequency and cost of PGS was high.